Androgen deprivation therapy (ADT) for prostate cancer
Friday, August 27th, 2010 Posted in hormone therapy | No Comments »A research team reviewed currently available data on the role of androgen deprivation therapy (ADT) in the management of early stage, high-risk prostate cancer. Researchers focus the majority of their attention on the value of adjuvant and neoadjuvant ADT in ...
Surgery better than radiation, hormone treatments for localized prostate cancer
Saturday, August 7th, 2010 Posted in hormone therapy, prostatectomy, radiation therapy | 1 Comment »Researchers at University of California, San Franciscosay (UCFS) the differences among therapies were more prominent at higher levels of cancer risk. They suggest that in many cases surgery should play a greater role in treatment strategies for patients with prostate ...
Blocking androgen response could be key for halting tumor progression in prostate cancer
Wednesday, July 21st, 2010 Posted in hormone therapy | No Comments »Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth. Previous studies showed that prostate cancer advances when tumors become ...
Lack of benefit for the ADT to dose-escalated RT in treatment of prostate cancer
Monday, July 19th, 2010 Posted in hormone therapy, radiation therapy | No Comments »Over the years, several randomized trials have shown the benefit of combining androgen deprivation therapy (ADT) with radiation therapy (RT) for the first- and second-line treatment of men with prostate cancer. A recent study at the William Beaumont Hospital in Michigan ...
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49
Monday, July 12th, 2010 Posted in hormone therapy, radiation therapy | No Comments »A Phase II trial related to high-affinity antibody CC49 was investigated in 15 patients with hormone-resistant metastatic prostate cancer. Acientists found no acute adverse reactions occurred, but all patients had evidence of an immune response to CC49 by 4 weeks and concluded CC49 ...
Modified Citrus Pectin holds effective against prostate cancer
Sunday, July 4th, 2010 Posted in hormone therapy | 2 Comments »A research team at Columbia University evaluated the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and ...
Radiation plus hormones boosts prostate cancer survival
Monday, June 7th, 2010 Posted in hormone therapy, radiation therapy | No Comments »Researchers are reporting a key advance in treating men with cancer that has started to spread beyond the prostate: survival is significantly better if radiation is added to standard hormone treatments. Results of the study were given Sunday at a cancer conference, ...
Tasquinimod in treatment of patients with metastatic CRPC
Monday, May 24th, 2010 Posted in hormone therapy | No Comments »Tasquinimod is an orally administered, investigational drug that has previously been shown to have both anti-angiogenic properties and anti-tumor activity in prostate cancer models. Earlier clinical trials of tasquinimod have shown that is well tolerated and that it may delay progression ...
New hormone treatment may fight resistant prostate cancer
Tuesday, April 20th, 2010 Posted in hormone therapy | No Comments »It was demonstrated that prostate tumors need testosterone to grow. By consequence, one treatment involves castration to combat the body's processing of testosterone, possibly with additional drug treatment. The problem is that there are castration-resistant prostate cancer forms. Though the treatment ...
Some prostate cancer patients prone to develop a blood clot
Thursday, April 15th, 2010 Posted in hormone therapy, prostate cancer | No Comments »New research says men with prostate cancer being treated with hormone therapy have a slightly higher risk of developing a blood clot, and the chance of developing blood clots increases with age, cancer and its treatment Study shows that while men ...